Cediranib treatment resulted, however, in an increase in mRNA level for CYP3A4 and CYP2R1 in melanoma cells pretreated with 1,25(OH)2D3 (p < 0.05 vs. control and vs. monotreatment, Figures 9C, D, respectively). The gene discussed is CYP2R1; the disease is melanoma.